
Virtus Silvant Small/Mid Growth ETF
Virtus Silvant Small/Mid Growth ETF (SSMG) Price & Chart
SSMG ETF Chart & Stats
- Day’s Range
- $22.65 - $22.65
- 52-Week Range
- $21.43 - $28.50
- Previous Close
- $22.87
- Volume
- 15
- Average Volume (3M)
- 205
- AUM
- 2.86M
- NAV
- 22.64
- Expense Ratio
- 0.39%
- Holdings Count
- 83
- Beta
- 1.64
- Inception Date
- Apr 21, 2026
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 125,004
- Standard Deviation
- N/A
ETF Overview
Virtus Silvant Small/Mid Growth ETF
Virtus Silvant Small/Mid Growth ETF (SSMG) is an actively managed U.S. equity ETF that seeks capital appreciation by investing primarily in small- and mid‑capitalization companies outside the large‑cap benchmark universe. Positioned in the Size & Style category and focused on the Extended Market growth niche, SSMG targets firms that exhibit above‑average growth characteristics—rapid revenue or earnings expansion, scalable business models, and market share momentum—often found across sectors such as technology, healthcare and consumer innovation. The fund employs a research‑driven, bottom‑up stock‑picking approach to build a concentrated, growth‑oriented portfolio designed to capture opportunities that passive large‑cap funds typically miss. SSMG is intended to complement core large‑cap holdings by providing exposure to the faster‑growing segment of the U.S. equity market; investors should expect greater return potential accompanied by higher volatility and a multi‑year investment horizon.
- Asset Class
- Equity
- Region
- North America
- Issuer
- Virtus
- Index Tracked
- No Underlying Index
- Ticker Symbol
- SSMG
SSMG ETF News


Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Study Overview: Neurocrine Biosciences’ official Phase 2 study, “A Prospective, Long-Term, Interventional, Active Extension Study to Evaluate the Safety












